Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Angelucci

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
Peptides|November 5, 2005
Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosisFrancesco Angelucci, Massimiliano Mirabella, Marcella Caggiula, et al.
Biotechnology for Biofuels and Bioproducts|December 12, 2022
Characterization of two 1,3-β-glucan-modifying enzymes from Penicillium sumatraense reveals new insights into 1,3-β-glucan metabolism of fungal saprotrophsValentina Scafati, Francesca Troilo, Sara Ponziani, et al.
Journal of Neuroinflammation|May 31, 2012
A single intraperitoneal injection of endotoxin in rats induces long-lasting modifications in behavior and brain protein levels of TNF-α and IL-18Paola Bossù, Debora Cutuli, Ilaria Palladino, et al.
Clinical Immunology (Orlando, Fla.)|November 9, 2005
Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapyMarcella Caggiula, Anna Paola Batocchi, Giovanni Frisullo, et al.
The Journal of Biological Chemistry|August 28, 2009
Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspectsFrancesco Angelucci, Ahmed A Sayed, David L Williams, et al.
Nanoscale|June 10, 2014
Metal-induced self-assembly of peroxiredoxin as a tool for sorting ultrasmall gold nanoparticles into one-dimensional clustersMatteo Ardini, Francesco Giansanti, Luana Di Leandro, et al.
Journal of Tissue Engineering and Regenerative Medicine|May 9, 2018
A peroxiredoxin-based proteinaceous scaffold for the growth and differentiation of neuronal cells and tumour stem cells in the absence of prodifferentiation agentsAnnamaria Cimini, Matteo Ardini, Roberta Gentile, et al.
Journal of Cellular Biochemistry|January 13, 2015
PDZ Domain in the Engineering and Production of a Saporin Chimeric Toxin as a Tool for targeting Cancer CellsFrancesco Giansanti, Domenica Sabatini, Maria Rosaria Pennacchio, et al.
International Journal of Molecular Sciences|October 27, 2022
Folding Mechanism and Aggregation Propensity of the KH0 Domain of FMRP and Its R138Q Pathological VariantDaniele Santorelli, Francesca Troilo, Francesca Fata, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|May 5, 2024
Clinical correlation between disease progression and central vein sign in pediatric onset multiple sclerosis: A binational studyShay Menascu, Simona Halusková, Amir Pollak, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
Peptides|November 5, 2005
Evidence of involvement of leptin and IL-6 peptides in the action of interferon-beta in secondary progressive multiple sclerosisFrancesco Angelucci, Massimiliano Mirabella, Marcella Caggiula, et al.
Biotechnology for Biofuels and Bioproducts|December 12, 2022
Characterization of two 1,3-β-glucan-modifying enzymes from Penicillium sumatraense reveals new insights into 1,3-β-glucan metabolism of fungal saprotrophsValentina Scafati, Francesca Troilo, Sara Ponziani, et al.
Journal of Neuroinflammation|May 31, 2012
A single intraperitoneal injection of endotoxin in rats induces long-lasting modifications in behavior and brain protein levels of TNF-α and IL-18Paola Bossù, Debora Cutuli, Ilaria Palladino, et al.
Clinical Immunology (Orlando, Fla.)|November 9, 2005
Neurotrophic factors in relapsing remitting and secondary progressive multiple sclerosis patients during interferon beta therapyMarcella Caggiula, Anna Paola Batocchi, Giovanni Frisullo, et al.
The Journal of Biological Chemistry|August 28, 2009
Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspectsFrancesco Angelucci, Ahmed A Sayed, David L Williams, et al.
Nanoscale|June 10, 2014
Metal-induced self-assembly of peroxiredoxin as a tool for sorting ultrasmall gold nanoparticles into one-dimensional clustersMatteo Ardini, Francesco Giansanti, Luana Di Leandro, et al.
Journal of Tissue Engineering and Regenerative Medicine|May 9, 2018
A peroxiredoxin-based proteinaceous scaffold for the growth and differentiation of neuronal cells and tumour stem cells in the absence of prodifferentiation agentsAnnamaria Cimini, Matteo Ardini, Roberta Gentile, et al.
Journal of Cellular Biochemistry|January 13, 2015
PDZ Domain in the Engineering and Production of a Saporin Chimeric Toxin as a Tool for targeting Cancer CellsFrancesco Giansanti, Domenica Sabatini, Maria Rosaria Pennacchio, et al.
International Journal of Molecular Sciences|October 27, 2022
Folding Mechanism and Aggregation Propensity of the KH0 Domain of FMRP and Its R138Q Pathological VariantDaniele Santorelli, Francesca Troilo, Francesca Fata, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|May 5, 2024
Clinical correlation between disease progression and central vein sign in pediatric onset multiple sclerosis: A binational studyShay Menascu, Simona Halusková, Amir Pollak, et al.
Pageof 17